The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_001323289.2(CDKL5):c.220G>T (p.Glu74Ter)

CA294584

156592 (ClinVar)

Gene: CDKL5 (HGNC:6792)
Condition: CDKL5 disorder (MONDO:0100039)
Inheritance Mode: X-linked inheritance
UUID: bbfab30d-9fcb-40a0-ab5c-fb65234c123b
Approved on: 2025-05-07
Published on: 2025-06-30

HGVS expressions

NM_001323289.2(CDKL5):c.220G>T (p.Glu74Ter)
NM_001323289.2:c.220G>T
NC_000023.11:g.18575428G>T
CM000685.2:g.18575428G>T
NC_000023.10:g.18593548G>T
CM000685.1:g.18593548G>T
NC_000023.9:g.18503469G>T
NG_008475.1:g.154824G>T
ENST00000623535.2:c.220G>T
ENST00000635828.1:c.220G>T
ENST00000637881.1:c.220G>T
ENST00000674046.1:c.220G>T
ENST00000379989.6:c.220G>T
ENST00000379996.7:c.220G>T
ENST00000463994.4:c.220G>T
ENST00000623535.1:c.220G>T
NM_001037343.1:c.220G>T
NM_003159.2:c.220G>T
NM_001323289.1:c.220G>T
NM_001037343.2:c.220G>T
NM_003159.3:c.220G>T
More

Pathogenic

Met criteria codes 3
PVS1 PM2_Supporting PS4_Moderate

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Rett and Angelman-like Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for CDKL5 Version 4.1.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Rett and Angelman-like Disorders VCEP
The p.Glu74Ter variant in CDKL5 is predicted to cause a premature stop codon that leads to a truncated or absent protein in a gene where loss-of-function is an established mechanism. There is significant evidence that loss of this region of the gene is pathogenic (PVS1). The p.Glu74Ter variant has been observed in 3 individuals with CDKL5-related disorders (PMID 3131328, PMID 25657822, GeneDx internal database) (PS4_moderate). The p.Glu74Ter variant in CDKL5 is absent from gnomAD v4.1 (PM2_Supporting). In summary, the p.Glu74Ter variant in CDKL5 is classified as pathogenic for CDKL5-related disorders based on the ACMG/AMP criteria (PVS1, PS4_moderate, PM2_supporting). (CDKL5 Specifications v4.1; curation approved on [5/7/2025])
Met criteria codes
PVS1
The p.Glu74Ter variant in CDKL5 is predicted to cause a premature stop codon that leads to a truncated or absent protein in a gene where loss-of-function is an established mechanism. There is significant evidence that loss of this region of the gene is pathogenic (PVS1).
PM2_Supporting
The p.Glu74Ter variant in CDKL5 is absent from gnomAD v4.1 (PM2_Supporting).
PS4_Moderate
The p.Glu74Ter variant has been observed in 3 individuals with CDKL5-related disorders (PMID 3131328, 25657822, GeneDx internal database) (PS4_moderate).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.